Revium Rx (RVRC) Total Current Liabilities (2024 - 2025)

Revium Rx (RVRC) reported Total Current Liabilities of $1.4 million for Q4 2025, up 137.67% on a YoY basis from $576000.0 in Q4 2024, and up 137.67% sequentially from $576000.0 in Q4 2024.

Revium Rx (RVRC) Total Current Liabilities (2024 - 2025) Analysis & Trends

Revium Rx (RVRC) has 2 years of Total Current Liabilities data on file, last reported at $1.4 million in Q4 2025.

  • For the quarter ending Q4 2025, Total Current Liabilities rose 137.67% year-over-year to $1.4 million; the trailing twelve-month figure through Dec 2025 stood at $1.4 million (up 137.67% YoY), and the FY2025 full-year result was $1.4 million, up 137.67% from the prior year.
  • Total Current Liabilities improved to $1.4 million in Q4 2025, from $576000.0 in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $1.4 million in Q4 2025 to a low of $576000.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Veeva Systems 29.34 Bn 22.03 Bn 662.02 Mn 1.70 Bn
2 BrightSpring Health Services 13.49 Bn 12.59 Bn 482.22 Mn 1.55 Bn
3 Healthequity 7.96 Bn 7.70 Bn 256.31 Mn 135.74 Mn
4 10x Genomics 6.17 Bn 5.63 Bn 106.18 Mn 113.60 Mn
5 Hinge Health 6.02 Bn 5.70 Bn 154.23 Mn 414.48 Mn
6 MiniMed 4.19 Bn 3.89 Bn 480.00 Mn 702.00 Mn
7 Waystar Holding 4.14 Bn 4.07 Bn 216.84 Mn 219.96 Mn
8 Doximity 3.82 Bn 3.08 Bn 125.97 Mn 154.97 Mn
9 Privia Health 3.10 Bn 2.73 Bn - 601.30 Mn
10 Revium Rx 101.42 Mn 98.71 Mn - 1.37 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.37 Mn
Dec 31, 2024 576,000.00